Beranda › Kanker Endometrium › Florida › Tampa
Uji klinis Kanker Endometrium di Tampa, FL
15 studi untuk Kanker Endometrium mencari peserta di lokasi sekitar Tampa (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Study of AVZO-021 in Patients With Advanced Solid Tumors
Menerima pesertaFase 1/2
- Avenzo Therapeutics Recruiting Site, Tampa
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Menerima pesertaFase 1
- Moffitt, Tampa
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Menerima pesertaFase 1/2
- Moffitt Cancer Center and Research Institute, Tampa
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
Menerima pesertaFase 3
- Women's Care - Armenia Ave, Tampa
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Menerima pesertaFase 3
- Research Site, Tampa
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
Menerima pesertaFase 1
- H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc., Tampa
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Menerima pesertaFase 1
- Moffitt Cancer Center, Tampa
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Menerima pesertaFase 3
- Research Site, Tampa
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1
- Investigative Site #128, Tampa
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Menerima pesertaFase 1/2
- Moffitt Cancer Center, Tampa
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Menerima pesertaFase 1
- Moffitt Cancer Center, Tampa
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Menerima pesertaFase 1/2
- Moffitt Cancer Center, Tampa
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
Menerima pesertaFase 1/2
- Moffitt Cancer Center and Research Institute, Tampa
A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.
Menerima pesertaFase 2
- H. Lee Moffitt Cancer Center and Research Institute, Inc., Tampa
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, Tampa
Uji klinis Kanker Endometrium di kota lain
- Houston, TX68 studi
- New York City, NY52 studi
- Boston, MA50 studi
- Arlington, VA39 studi
- Nashville, TN38 studi
- Los Angeles, CA34 studi
- St. Louis, MO29 studi
- Philadelphia, PA28 studi
- San Antonio, TX27 studi
- Columbus, OH25 studi
- Chicago, IL25 studi
- Oklahoma City, OK25 studi
Studi lain di Tampa
- Kanker Paru Non-Sel Kecil51 studi
- Kanker Payudara43 studi
- Kanker (semua jenis)39 studi
- Kanker Kolorektal34 studi
- Leukemia Mieloid Akut29 studi
- Kanker Metastatik29 studi
- Kanker Paru29 studi
- Kanker Pankreas26 studi
- Kanker Ovarium21 studi
- Melanoma19 studi
- Sindrom Mielodisplastik19 studi
- Kanker Prostat18 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.